Renee Schenning, RN | |
424 Savannah Rd, Lewes, DE 19958-1462 | |
(302) 645-3300 | |
Not Available |
Full Name | Renee Schenning |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 424 Savannah Rd, Lewes, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528595162 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | R149427 (Maryland) | Secondary |
163W00000X | Registered Nurse | R149427 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Renee Schenning, RN 3225 Uniontown Way, Abingdon, MD 21009-2508 Ph: (410) 790-9896 | Renee Schenning, RN 424 Savannah Rd, Lewes, DE 19958-1462 Ph: (302) 645-3300 |
News Archive
Asked to sample two identical foods from the fast-food giant McDonald's, children preferred the taste of the version branded with the restaurant's familiar "Golden Arches" to one extracted from unmarked paper packaging, say researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
Pulsar Vascular, an innovative medical device company, focused on breakthrough technology in the neurovascular space, announced today that they have reached the target enrollment in their clinical trial for PulseRider, the company's lead product.
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter of 2010.
› Verified 6 days ago